A group of scientists from Saitama Medical University in Japan have revealed promising results in a study on treating pleural effusion or a build-up of fluid in the lungs. This common symptom for mesothelioma patients tends to cause chest pain, shortness of breath and a daunting full body fatigue. The standard procedures for dealing with the fluid include a very invasive surgical procedure or by chemically sealing the place where the fluid builds up.
The Japanese doctors used a procedure called hyperthermic chemotherapy (IPHC) in conjunction with the drug cisplatin. The main ingredient in cisplatin is platinum.
The study included 21 patients suffering from pleural effusion, 7 of which had been diagnosed with mesothelioma (almost all mesothelioma patients also suffer from effusion). The results were very impressive. All 21 patients' results included complete effusion control three months after the treatment. Read the full study here.
We are hopeful that this will continue to contribute to a better quality of life for those who have been diagnosed and are living with mesothelioma.
The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma due to asbestos exposure, call the Paul Law Firm. With over 2 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn't just happen in the courtroom it also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.
Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers.
